BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23354190)

  • 1. Relationship between serum leptin levels and bone mineral density and bone metabolic markers in patients on hemodialysis.
    Ahmadi F; Salari S; Maziar S; Esfahanian F; Khazaeipour Z; Ranjbarnovin N
    Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):41-7. PubMed ID: 23354190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with low bone mass in the hemodialysis patients--a cross-sectional correlation study.
    Huang GS; Chu TS; Lou MF; Hwang SL; Yang RS
    BMC Musculoskelet Disord; 2009 Jun; 10():60. PubMed ID: 19497099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
    Ghannam NN; Hammami MM; Bakheet SM; Khan BA
    Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients.
    Sit D; Kadiroglu AK; Kayabasi H; Atay AE; Yilmaz Z; Yilmaz ME
    Adv Ther; 2007; 24(5):987-95. PubMed ID: 18029324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between leptin and adiponectin concentrations in plasma and femoral and spinal bone mineral density in spinal cord-injured individuals.
    Sabour H; Norouzi Javidan A; Latifi S; Shidfar F; Vafa MR; Emami Razavi SH; Larijani B; Heshmat R
    Spine J; 2015 Jan; 15(1):1-9. PubMed ID: 24948038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineral bone disorder and osteoporosis in hemodialysis patients.
    Slouma M; Sahli H; Bahlous A; Laadhar L; Smaoui W; Rekik S; Gharsallah I; Sallami M; Moussa FB; Elleuch M; Cheour E
    Adv Rheumatol; 2020 Feb; 60(1):15. PubMed ID: 32102689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients.
    Jeong JU; Lee HK; Kim YJ; Kim JS; Kang SS; Kim SB
    Clin Nephrol; 2010 Nov; 74(5):336-42. PubMed ID: 20979940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral densitometry in patients on hemodialysis: difference between genders and what to measure.
    Orlic L; Crncevic Z; Pavlovic D; Zaputovic L
    Ren Fail; 2010 Jan; 32(3):300-8. PubMed ID: 20370444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women.
    Filip R; Raszewski G
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):214-20. PubMed ID: 18547340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum leptin, adiponectin and ghrelin concentrations in post-menopausal women: Is there an association with bone mineral density?
    Mpalaris V; Anagnostis P; Anastasilakis AD; Goulis DG; Doumas A; Iakovou I
    Maturitas; 2016 Jun; 88():32-6. PubMed ID: 27105694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density and parathyroid function in patients on maintenance hemodialysis.
    Ambrus C; Almasi C; Berta K; Deak G; Marton A; Molnar MZ; Nemeth Z; Horvath C; Lakatos P; Szathmari M; Mucsi I
    Int Urol Nephrol; 2011 Mar; 43(1):191-201. PubMed ID: 20091221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of bone mineral density in renal transplantation recipients.
    Unal A; Kocyigit I; Sipahioglu MH; Tokgoz B; Kavuncuoglu F; Oymak O; Utas C
    Transplant Proc; 2010 Nov; 42(9):3550-3. PubMed ID: 21094813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
    Zheng S; Chen Y; Zheng Y; Zhou Z; Li Z
    Eur J Med Res; 2018 Apr; 23(1):18. PubMed ID: 29665846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.
    Ersoy FF; Passadakis SP; Tam P; Memmos ED; Katopodis PK; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis JG; Dombros AN; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis PC; Yavuz M; Tsakiris JD; Dimitriades CA; Yilmaz ME; Gültekin M; Karayalçin B; Yardimsever M; Oreopoulos DG
    J Bone Miner Metab; 2006; 24(1):79-86. PubMed ID: 16369903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis.
    Yavropoulou MP; Vaios V; Pikilidou M; Chryssogonidis I; Sachinidou M; Tournis S; Makris K; Kotsa K; Daniilidis M; Haritanti A; Liakopoulos V
    J Clin Densitom; 2017; 20(4):490-497. PubMed ID: 28039046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum adiponectin and bone mineral density in male hemodialysis patients.
    Okuno S; Ishimura E; Norimine K; Tsuboniwa N; Kagitani S; Yamakawa K; Yamakawa T; Sato KK; Hayashi T; Shoji S; Nishizawa Y; Inaba M
    Osteoporos Int; 2012 Jul; 23(7):2027-35. PubMed ID: 21927917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.